|
POLB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.34580174466259E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.51270000029002E-07 |
| Normal-vs-Stage2 |
3.49990000314548E-08 |
| Normal-vs-Stage3 |
2.63049582116537E-11 |
| Normal-vs-Stage4 |
1.80355730350357E-12 |
| Stage1-vs-Stage2 |
1.738780E-01 |
| Stage1-vs-Stage3 |
2.147500E-02 |
| Stage1-vs-Stage4 |
3.5392000000023E-05 |
| Stage2-vs-Stage3 |
5.739200E-01 |
| Stage2-vs-Stage4 |
1.737570E-02 |
| Stage3-vs-Stage4 |
3.937600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.01599864474633E-11 |
| Normal-vs-AfricanAmerican |
4.27589999996147E-06 |
| Normal-vs-Asian |
3.99070000001167E-06 |
| Caucasian-vs-AfricanAmerican |
7.007600E-01 |
| Caucasian-vs-Asian |
4.286000E-01 |
| AfricanAmerican-vs-Asian |
3.915600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.05949999884558E-08 |
| Normal-vs-Female |
1.48050016690604E-10 |
| Male-vs-Female |
7.444000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.16829999954982E-07 |
| Normal-vs-Age(41-60Yrs) |
8.26360091465972E-11 |
| Normal-vs-Age(61-80Yrs) |
5.25040011467581E-10 |
| Normal-vs-Age(81-100Yrs) |
2.884000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.619900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.169700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.685400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.354400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.396600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.088200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.903900E-03 |
| Classical-VS-Follicular |
5.099900E-02 |
| Classical-VS-Other |
2.018800E-01 |
| Classical-VS-Normal |
9.87609993785554E-12 |
| Tall-VS-Follicular |
6.032500E-04 |
| Tall-VS-Other |
5.639600E-02 |
| Tall-VS-Normal |
1.93020044392256E-11 |
| Follicular-VS-Other |
1.874390E-01 |
| Follicular-VS-Normal |
6.34529999999911E-05 |
| Other-VS-Normal |
8.457600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.45159999973299E-08 |
| Normal-vs-N1 |
3.11609626990617E-11 |
| N0-vs-N1 |
1.270330E-02 |
|
|
